| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $90.5M | +8.0% |
| Cost of Revenue | $23.4M | +7.2% |
| Gross Profit | $67.1M | +8.3% |
| R&D Expense | $19.5M | +10.9% |
| SG&A Expense | $101.3M | -0.8% |
| Operating Income | -$53.7M | +7.0% |
| Pre-tax Income | -$53.4M | +4.5% |
| Income Tax | $626K | +25.2% |
| Net Income | -$54.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $69.8M | -1.6% |
| Accounts Receivable | $12.1M | -8.0% |
| Inventory | $15.8M | -6.3% |
| Current Assets | $101.7M | -25.4% |
| Total Assets | $129.3M | -20.6% |
| Current Liabilities | $20.1M | -17.9% |
| Long-term Debt | $37.1M | -0.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$32.4M | -2.7% |
| Capital Expenditures | $452K | -68.8% |
| Investing Cash Flow | $30.5M | +74.4% |
| Financing Cash Flow | $833K | -38.9% |
| Free Cash Flow | -$32.8M | +0.5% |
| +4.2% |
| EPS (Basic) | -$1.33 | +7.6% |
| EPS (Diluted) | -$1.33 | +7.6% |
| Total Liabilities |
| $75.2M |
| -2.4% |
| Stockholders' Equity | $54.1M | -36.9% |